Pharma Aids Limited

DSE:PHARMAID Stock Report

Market Cap: ৳1.6b

Pharma Aids Past Earnings Performance

Past criteria checks 2/6

Pharma Aids's earnings have been declining at an average annual rate of -12.6%, while the Packaging industry saw earnings growing at 8% annually. Revenues have been growing at an average rate of 11.9% per year. Pharma Aids's return on equity is 18.7%, and it has net margins of 15.6%.

Key information

-12.6%

Earnings growth rate

-12.6%

EPS growth rate

Packaging Industry Growth2.6%
Revenue growth rate11.9%
Return on equity18.7%
Net Margin15.6%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Pharma Aids makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

DSE:PHARMAID Revenue, expenses and earnings (BDT Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2443167440
30 Jun 2442161440
31 Mar 2440951450
31 Dec 2337624430
30 Sep 23329-1380
30 Jun 23308-6370
31 Mar 23302-13460
31 Dec 223035460
30 Sep 2231025460
30 Jun 2232335470
31 Mar 2232560400
31 Dec 2131558390
30 Sep 2130154390
30 Jun 2128050380
31 Mar 2127246370
31 Dec 2025547350
30 Sep 2026251340
30 Jun 2027052340
30 Jun 1924948300
30 Jun 1823547260
31 Mar 1822746240
31 Dec 1721239240
30 Sep 1719335220
30 Jun 1718030210
31 Mar 1717628200
31 Dec 1616626190
30 Sep 1616125180
30 Jun 1615223170
31 Mar 1613923170
31 Dec 1513722160
30 Sep 1513823160
30 Jun 1514725150
31 Mar 1515427160
31 Dec 1415027150
30 Sep 1413722140
30 Jun 1412617140
31 Mar 1411212130

Quality Earnings: PHARMAID has high quality earnings.

Growing Profit Margin: PHARMAID became profitable in the past.

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: PHARMAID's earnings have declined by 12.6% per year over the past 5 years.

Accelerating Growth: PHARMAID has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: PHARMAID has become profitable in the last year, making it difficult to compare its past year earnings growth to the Packaging industry (14.3%).

Return on Equity

High ROE: PHARMAID's Return on Equity (18.7%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/30 02:36
End of Day Share Price 2025/01/30 00:00
Earnings2024/09/30
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Pharma Aids Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution